Wave Life Sciences (WVE) Interest & Investment Income (2020 - 2026)
Wave Life Sciences (WVE) posted Interest & Investment Income of $5.3 million for Q1 2026, up 73.25% on a QoQ basis from $3.1 million in Q4 2025, and up 84.03% year-over-year from $2.9 million in Q1 2025.
Wave Life Sciences (WVE) Interest & Investment Income (2020 - 2026) Analysis & Trends
Wave Life Sciences' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $5.3 million for Q1 2026.
- Quarterly Interest & Investment Income rose 84.03% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.9 million (up 22.76% YoY) and the FY2025 annual result came in at $10.5 million, up 3.1% from the prior year.
- Interest & Investment Income was $5.3 million for Q1 2026 at Wave Life Sciences, up from $3.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.3 million in Q1 2026 and bottomed at $26000.0 in Q1 2022.
- A 5-year average of $2.1 million and a median of $2.1 million in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 16400.0% — and 2025, when it slipped 18.3%.
- Wave Life Sciences' Interest & Investment Income stood at $825000.0 in 2022, then soared by 123.52% to $1.8 million in 2023, then surged by 102.71% to $3.7 million in 2024, then dropped by 18.3% to $3.1 million in 2025, then soared by 73.25% to $5.3 million in 2026.
- Business Quant data shows WVE's Interest & Investment Income at $5.3 million in Q1 2026, $3.1 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Wave Life Sciences | 1.19 Bn | 649.41 Mn | - | 5.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.29 Mn |
| Dec 31, 2025 | 3.05 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | 3.74 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Mar 31, 2024 | 2.54 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | 1.96 Mn |
| Jun 30, 2023 | 2.25 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | 825,000.00 |
| Sep 30, 2022 | 596,000.00 |
| Jun 30, 2022 | 124,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 8,000.00 |